2003
DOI: 10.1016/j.thromres.2003.10.010
|View full text |Cite
|
Sign up to set email alerts
|

A comparison of fibrin sealants in relation to their in vitro and in vivo properties

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
58
0
2

Year Published

2006
2006
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 76 publications
(64 citation statements)
references
References 23 publications
4
58
0
2
Order By: Relevance
“…Isolation techniques (eg, cryoprecipitation and ethanol precipitation), batch to batch variability, and composition (eg, concentration of thrombin, fibrinogen, factor XIII, and antifibrolytics) lead to different mechanical and biological properties of the generated clots. 16,17 For example, Dickneite et al showed clear differences in hemostatic and clot strength properties of 12 commercially available fibrin sealants. 17 Furthermore, differences in component origin may change the biochemistry of the clot, like interspecies or pooled and single donor.…”
Section: Difficulties Involved In Assessing the Literaturementioning
confidence: 99%
See 1 more Smart Citation
“…Isolation techniques (eg, cryoprecipitation and ethanol precipitation), batch to batch variability, and composition (eg, concentration of thrombin, fibrinogen, factor XIII, and antifibrolytics) lead to different mechanical and biological properties of the generated clots. 16,17 For example, Dickneite et al showed clear differences in hemostatic and clot strength properties of 12 commercially available fibrin sealants. 17 Furthermore, differences in component origin may change the biochemistry of the clot, like interspecies or pooled and single donor.…”
Section: Difficulties Involved In Assessing the Literaturementioning
confidence: 99%
“…16,17 For example, Dickneite et al showed clear differences in hemostatic and clot strength properties of 12 commercially available fibrin sealants. 17 Furthermore, differences in component origin may change the biochemistry of the clot, like interspecies or pooled and single donor. 18,19 Variations in experimental design, implantation site, and animal models as well as fibrinogen and thrombin concentrations are other parameters that make direct comparison of the research findings difficult.…”
Section: Difficulties Involved In Assessing the Literaturementioning
confidence: 99%
“…Fibrin glues (FGs) are mainly exploited from pooled plasma and consist of different amounts of purified and virally inactivated human proteins: fibrinogen, thrombin, factor XIII, anti-fibrinolytic agents, and calcium chloride. Fibrin scaffolds can be used as a principal element in TE approaches and provide complete autologous construction (Dickneite et al 2003;Montana et al 2012). Alginate is shown as a nontoxic hydrogel scaffold and hence has been used in TE for culturing of chondrocytes (Ning 2011).…”
Section: Introductionmentioning
confidence: 99%
“…In commercial sealants the thrombin activity has been reported at 4-1000 IU/ml [4,5] and the fibrinogen concentration at 19.88 mg/ml, 35-55 mg/ml and 80-100 mg/ml [4][5][6].…”
Section: Introductionmentioning
confidence: 99%
“…The adhesive properties of fibrin glue preparations are used to classify the products and are often evaluated via tensile testing [1,[5][6][7]. Tensile testing of fibrin glue has been reported using vital human tissue [6], rat or pig skin and canine or rat models [7].…”
Section: Introductionmentioning
confidence: 99%